Maravai LifeSciences Holdings, Inc. MRVI
7.70 USD -0.16 (-2.04%)
At closeNov 11, 2026, 4:55 PM EST
7.50 -0.20 -2.60%
After hours · Nov 11, 4:55 PM ET
7.68 Day range 8.18
2.80 52-week range 9.42
- YTD
- +136.92%
- 1 year
- +136.92%
News
seekingalpha.com Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2026 Earnings Call Transcript Maravai LifeSciences Holdings, Inc. ( MRVI ) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Company Participants Debra Hart - Senior Director of Investor Relations Bernd Brust - CEO & Director…
marketbeat.com What Maravai LifeSciences (MRVI) Said on Its Q3 Earnings Call Maravai LifeSciences NASDAQ: MRVI raised its 2026 revenue and adjusted EBITDA forecasts after reporting third-quarter sales growth of 10%, driven by demand for mRNA products and continued growth at…
zacks.com Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Beats Revenue Estimates Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.08 per share a year…
benzinga.com Maravai LifeSciences Q3 2026 Earnings Call Transcript Maravai LifeSciences (NASDAQ:MRVI) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Maravai LifeSciences Raises FY2026 Sales Guidance from $205.000M-$215.000M to $212.000M-$216.000M vs $211.767M Est Maravai LifeSciences (NASDAQ:MRVI) raises FY2026 sales outlook from $205.000 million-$215.000 million to $212.000 million-$216.000 million vs $211.767 million estimate.
benzinga.com Maravai LifeSciences Q3 Adj. EPS $(0.03) Beats $(0.06) Estimate, Sales $45.851M Beat $43.566M Estimate Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. This is a 62.5 percent increase over losses of…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the…
businesswire.com Maravai LifeSciences Reports Third Quarter 2026 Financial Results SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported…
benzinga.com Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call Maravai LifeSciences (NASDAQ:MRVI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is…
benzinga.com UBS Maintains Neutral on Maravai LifeSciences, Raises Price Target to $8 UBS analyst Dan Brennan maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and raises the price target from $2.5 to $8.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 34.0% to $1.26 during Thursday's regular session. The company's market cap stands at $125.2 million. BioVie (NASDAQ:BIVI) stock…
benzinga.com Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
benzinga.com Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
benzinga.com Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $6.5 Wells Fargo analyst Evan Stampler maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $5.5 to $6.5.- benzinga.com Maravai LifeSciences Affirms FY2026 Sales Guidance of $205.000M-$215.000M vs $210.433M Est Maravai LifeSciences (NASDAQ:MRVI) affirms FY2026 sales outlook from $205.000 million-$215.000 million to $205.000 million-$215.000 million vs $210.433 million estimate.
- benzinga.com Maravai LifeSciences' TriLink BioTechnologies Obtains New Patent From The China National Intellectual Property Administration, Patent Number ZL 2025 1 1246578.X TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $5.5 Wells Fargo analyst Brandon Couillard maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $4.5 to $5.5.
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Maravai LifeSciences Raises FY2026 Sales Guidance from $200.000M-$210.000M to $205.000M-$215.000M vs $204.933M Est Maravai LifeSciences (NASDAQ:MRVI) raises FY2026 sales outlook from $200.000 million-$210.000 million to $205.000 million-$215.000 million vs $204.933 million estimate.- benzinga.com Maravai LifeSciences Q1 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $65.837M Beat $53.046M Estimate Maravai LifeSciences (NASDAQ:MRVI) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 112.5 percent increase over losses of…
benzinga.com Earnings Scheduled For February 25, 2026 
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com Earnings Scheduled For August 11, 2025 
benzinga.com Earnings Scheduled For May 12, 2025 
benzinga.com Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday 
benzinga.com Earnings Scheduled For February 25, 2025 
benzinga.com Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 
benzinga.com BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.- benzinga.com Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.
- benzinga.com Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.
- benzinga.com Earnings Scheduled For February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
- benzinga.com Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.
- benzinga.com US Stocks Set To Snap Winning Streak, Treasuries Rally, Oil Tumbles: What's Driving Markets Wednesday? U.S. stocks experienced a drop as of midday trading in New York, potentially ending a prolonged streak of consecutive daily gains as investors evaluate the economic outlook. Commodity prices…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 188 companies set new 52-week lows.
- benzinga.com Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the…
- benzinga.com Earnings Scheduled For August 7, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 103 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 46 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 59 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday saw 59 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 212 companies made new 52-week lows.
- benzinga.com Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
- benzinga.com Earnings Scheduled For May 8, 2023 Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.